TY - JOUR
T1 - Neuropsychological effects of 2-week continuous positive airway pressure treatment and supplemental oxygen in patients with obstructive sleep apnea
T2 - A randomized placebo-controlled study
AU - Lim, Weonjeong
AU - Bardwell, Wayne A.
AU - Loredo, Jose S.
AU - Kim, Eui Joong
AU - Ancoli-Israel, Sonia
AU - Morgan, Erin E.
AU - Heaton, Robert K.
AU - Dimsdale, Joel E.
PY - 2007/6/15
Y1 - 2007/6/15
N2 - Study Objectives: To determine predictors of neuropsychological functioning in patients with obstructive sleep apnea (OSA) and whether treatment with 2-week continuous positive airway pressure (CPAP) or supplemental oxygen would improve cognitive functioning. Design: Randomized placebo-controlled design. Setting: University-based clinical research center. Patients: Forty-six patients with untreated OSA. Interventions: Two-week CPAP, supplemental oxygen, or placebo-CPAP. Measurements and Results: Participants underwent polysomnography and completed a neuropsychological test battery before and after treatment. Prior to treatment, patients with OSA showed diffuse impairments, particularly in terms of speed of information processing, attention and working memory, executive functioning, learning and memory, as well as alertness and sustained attention. A global deficit score at baseline was positively correlated with percentage of stage 1 sleep (p = .049) only and was not correlated with obesity, daytime sleepiness, depression, fatigue, OSA severity, and the other polysomnography variables. The 3 treatment groups (therapeutic-CPAP, supplemental oxygen, and placebo-CPAP) were compared using repeated-measures analysis of variance (ANOVA). There was no significant Time x Treatment interaction for the global deficit score. When examining individual neuropsychological test scores, two thirds of them improved with time regardless of treatment, although only Digit Vigilance - Time (p = .020) showed significant improvement specific to CPAP treatment. Conclusion: The present results suggest that Digit Vigilance - Time might be the most sensitive neuropsychological test for measuring the effects of the treatments. In general, 2 weeks of CPAP or oxygen-supplementation treatment was insufficient to show overall beneficial cognitive effects, as compared with placebo-CPAP. However, 2 weeks of CPAP treatment might be helpful in terms of speed of information processing, vigilance, or sustained attention and alertness.
AB - Study Objectives: To determine predictors of neuropsychological functioning in patients with obstructive sleep apnea (OSA) and whether treatment with 2-week continuous positive airway pressure (CPAP) or supplemental oxygen would improve cognitive functioning. Design: Randomized placebo-controlled design. Setting: University-based clinical research center. Patients: Forty-six patients with untreated OSA. Interventions: Two-week CPAP, supplemental oxygen, or placebo-CPAP. Measurements and Results: Participants underwent polysomnography and completed a neuropsychological test battery before and after treatment. Prior to treatment, patients with OSA showed diffuse impairments, particularly in terms of speed of information processing, attention and working memory, executive functioning, learning and memory, as well as alertness and sustained attention. A global deficit score at baseline was positively correlated with percentage of stage 1 sleep (p = .049) only and was not correlated with obesity, daytime sleepiness, depression, fatigue, OSA severity, and the other polysomnography variables. The 3 treatment groups (therapeutic-CPAP, supplemental oxygen, and placebo-CPAP) were compared using repeated-measures analysis of variance (ANOVA). There was no significant Time x Treatment interaction for the global deficit score. When examining individual neuropsychological test scores, two thirds of them improved with time regardless of treatment, although only Digit Vigilance - Time (p = .020) showed significant improvement specific to CPAP treatment. Conclusion: The present results suggest that Digit Vigilance - Time might be the most sensitive neuropsychological test for measuring the effects of the treatments. In general, 2 weeks of CPAP or oxygen-supplementation treatment was insufficient to show overall beneficial cognitive effects, as compared with placebo-CPAP. However, 2 weeks of CPAP treatment might be helpful in terms of speed of information processing, vigilance, or sustained attention and alertness.
KW - Cognitive function
KW - Continuous positive airway pressure
KW - Neuropsychology
KW - Obstructive sleep apnea
KW - Oxygen supplementation
KW - Placebo
UR - http://www.scopus.com/inward/record.url?scp=34250807248&partnerID=8YFLogxK
U2 - 10.5664/jcsm.26860
DO - 10.5664/jcsm.26860
M3 - Article
C2 - 17694727
AN - SCOPUS:34250807248
SN - 1550-9389
VL - 3
SP - 380
EP - 386
JO - Journal of Clinical Sleep Medicine
JF - Journal of Clinical Sleep Medicine
IS - 4
ER -